Market News AIOpen the app

CNSY stock news · Cerenome, Inc.

Stories about Cerenome, Inc. (CNSY) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CNSY

Follow Cerenome, Inc. (CNSY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CNSY
Free on the App Store and Google Play, or on the web.
  1. Nov 13, 2026, 4:54 PM ET · Market

    Cerenome, Inc. shared its third-quarter results, showing growth in diagnostic revenue and progress on its REYOBIQ treatment.

    Good for CNSY

    Cerenome recorded $0.7 million in net CNSide test sales and expanded insurer coverage to about 190 million covered lives. This supports a positive read, though Medicare coverage is still pending.